Relevance of polyclonal plasma cells and post‐therapy immunomodulation in measurable residual disease assessment in multiple myeloma
暂无分享,去创建一个
V. Prajapati | R. Sahoo | A. Gogia | Ritu Gupta | Atul Sharma | N. Das | S. Rai | Saroj Singh | L. Kumar | M. Dahiya